DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹2,738 Cr | ₹1,653 Cr | ₹1,261 Cr | ₹2,459 Cr | ₹1,912 Cr |
What is the latest Cash Flow from Operating Activities ratio of DIVIS LABORATORIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹2,738 Cr |
| Mar2025 | ₹1,653 Cr |
| Mar2024 | ₹1,261 Cr |
| Mar2023 | ₹2,459 Cr |
| Mar2022 | ₹1,912 Cr |
How is Cash Flow from Operating Activities of DIVIS LABORATORIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,738 Cr | 65.64 | |
| Mar2025 | ₹1,653 Cr | 31.09 | |
| Mar2024 | ₹1,261 Cr | -48.72 | |
| Mar2023 | ₹2,459 Cr | 28.62 | |
| Mar2022 | ₹1,912 Cr | - | |
Compare Cash Flow from Operating Activities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹196,904.1 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,832.0 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| MANKIND PHARMA | ₹105,357.0 Cr | -1% | 3.7% | -5.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 1.2% |
10.5% |
7.7% |
| SENSEX | -1.1% |
-0.2% |
-6.6% |
You may also like the below Video Courses